Apyx Medical Corporation (APYX) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Apyx Medical Corporation.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04165-4a1f-73a3-8842-fbb560fd28ee Created: 2026-08-27T04:05:53.578Z Duration: 1557.048 Channels: 1 00:00:00.640 -- 00:00:03.520 Good afternoon, ladies and gentlemen, and welcome to 00:00:03.520 -- 00:00:05.120 the APYX Medical 00:00:05.200 -- 00:00:06.000 2Q 00:00:06.000 -- 00:00:08.160 'twenty six Earnings Conference Call. 00:00:08.320 -- 00:00:10.719 At this time, all lines are in a 00:00:10.719 -- 00:00:11.759 listen only mode. 00:00:12.264 -- 00:00:14.905 Following the presentation, we will conduct a question 00:00:14.905 -- 00:00:16.184 and answer session. 00:00:16.664 -- 00:00:17.785 This 00:00:24.425 -- 00:00:29.050 call is being recorded on Thursday, 08/06/2026. 00:00:29.609 -- 00:00:31.689 I would now like to turn the conference 00:00:31.689 -- 00:00:34.090 over to Jeremy Feffer, 00:00:34.329 -- 00:00:35.770 LifeSci Advisors. 00:00:35.930 -- 00:00:37.050 Please go ahead. 00:00:38.329 -- 00:00:40.809 Thank you, and welcome, everyone, to our second 00:00:40.809 -- 00:00:42.650 quarter twenty twenty six earnings call. 00:00:43.345 -- 00:00:45.505 Representing the company on the call are Charlie 00:00:45.505 -- 00:00:48.385 Goodwin, Chief Executive Officer and Matt Hill, Chief 00:00:48.385 -- 00:00:50.065 Financial Officer of APYX. 00:00:50.465 -- 00:00:52.465 Before we begin, I would like to remind 00:00:52.465 -- 00:00:54.545 everyone that our remarks and responses to your 00:00:54.545 -- 00:00:57.345 questions today may contain forward looking statements that 00:00:57.345 -- 00:00:59.780 are based on the current expectations of management 00:00:59.940 -- 00:01:02.580 and involve inherent risks and uncertainties that could 00:01:02.580 -- 00:01:05.220 cause actual results to differ materially from t...